Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00782145 · ClinicalTrials.gov registry record · Phase 3
A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families
A Phase 3 study of Ovarian Cancer and Lymphoma, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 198
- Enrollment target
- 6
- Study locations
NCT00782145 is a Phase 3 study of Ovarian Cancer and Lymphoma that has completed, run by Tufts Medical Center. The registered enrollment target is 198 participants, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (73% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT00782145, a Phase 3 study of Ovarian Cancer and Lymphoma, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 198 participants
- Enrollment target
- 6
- Study locations
Study Summary
RATIONALE: A Web site for stem cell transplant health information and support may be effective in helping parents improve their health-related knowledge, skills, and quality of life, which may also improve their children's quality of life. PURPOSE: This randomized phase III trial is studying a Web-based stem cell transplant support system to see how well it works compared with standard care in families of young patients undergoing a stem cell transplant.
Conditions Studied
Interventions
- OTHER questionnaire administration
- OTHER educational intervention
- OTHER study of socioeconomic and demographic variables
- OTHER informational intervention
- OTHER internet-based intervention
Study Locations (6)
California
- City of Hope Comprehensive Cancer Center - Duarte
Massachusetts
- Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute - Boston
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Wisconsin
- Medical College of Wisconsin Cancer Center - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00782145
The ClinicalTrials.gov registry entry for NCT00782145 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (73% lower). The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 5 interventions - of which questionnaire administration is the first listed.
NCT00782145 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Massachusetts, Ohio.
Frequently Asked Questions
What is clinical trial NCT00782145 about?
NCT00782145 is a clinical study titled "A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families". RATIONALE: A Web site for stem cell transplant health information and support may be effective in helping parents improve their health-related knowledge, skills, and quality of life, which may also improve their children's quality of life. PURPOSE: This randomized phase III trial is studying a Web-...
What is the current status of trial NCT00782145?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 198 participants. The study started on 2008-06. Estimated completion is 2011-06.
What conditions does trial NCT00782145 study?
This clinical trial studies the following conditions: Ovarian Cancer, Lymphoma, Leukemia, Myelodysplastic Syndromes, Sarcoma.
What interventions are being tested in trial NCT00782145?
The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER), study of socioeconomic and demographic variables (OTHER), informational intervention (OTHER), internet-based intervention (OTHER).
Who is sponsoring clinical trial NCT00782145?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00782145 being conducted?
This trial has 6 study locations across California, Massachusetts, Ohio, Pennsylvania, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
RECRUITING · Phase 3
-
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RECRUITING · Phase 3
-
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
RECRUITING · Phase 3
-
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
RECRUITING · Phase 3
-
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RECRUITING · Phase 3
-
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.